“‘We’re proud to be supporting Steel Therapeutics at this key stage of their development journey,’ said Steve Mason, Co-COO. ‘Our teams are aligned in their commitment to accelerate the delivery of patient-centered therapies.’”

“The funding round was led by a group of new strategic investors and will help the company advance a pivotal toxicology study later this year and prepare for submission of an Investigational New Drug (IND) application.”

“Founded in 2020 by Matt Stahl and Robbie Schwenker, the company hopes to take compounding drugs through the FDA approval process, making them more widely and easily available.”

“Steel Therapeutics is a pharmaceutical company founded by Matt Stahl, Robbie Schwenker, and Allen Phillips . . . The team is working to bring innovations in compounding drugs to the masses. Compounding drugs are not FDA approved”

“Stahl said he didn’t mind not getting to work with coaches and fellow participants in person. In fact, he believes the opportunity to work virtually actually helped Steel as he expects to be doing a lot of virtual pitches to investors.”

“‘The FDA did not object to our proposed development path and otherwise offered feedback aligned our vision and desired timeline,’ said Steel CEO and Founder Matt Stahl. ‘The correspondence gives us confidence in our approach to bringing the Fizurex wipe to patients at scale.’”

“‘The FDA did not object to our proposed development path and otherwise offered feedback that is aligned our vision and desired timeline,’ said Steel CEO and Founder Matt Stahl. ‘The correspondence gives us confidence in our approach to bringing the Fizurex wipe to patients at scale.’”